SAFIR cohort: One-year prospective follow-up of very old and frail patients treated with direct oral anticoagulant, rivaroxaban
| Autor: | Hanon, O., Chaussade, E., David, J.P., Boulloche, N., Vinsonneau, U., Fauchier, L., Krolak-Salmon, P., Jouanny, P., Sacco, G., Lilamand, M., Paillaud, E., Guerin, O., Bonnefoy, M., Mahe, I., Toulza, O., Berrut, G., Vidal, J. |
|---|---|
| Zdroj: | In Archives of Cardiovascular Diseases Supplements January 2020 12(1):115-115 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect